{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T04:57:59Z","timestamp":1785560279293,"version":"3.56.0"},"reference-count":19,"publisher":"Japanese Society of Internal Medicine","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,8,1]]},"DOI":"10.2169\/internalmedicine.5550-25","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T22:07:43Z","timestamp":1766009263000},"page":"2106-2111","source":"Crossref","is-referenced-by-count":1,"title":["Development of Marine-Lenhart Syndrome during the Course of Acromegaly"],"prefix":"10.2169","volume":"65","author":[{"given":"Momo","family":"Saito","sequence":"first","affiliation":[{"name":"The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Okada","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumi","family":"Uemura","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiya","family":"Tanaka","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Yang H, Zhang MZ, Wei J, et al. Risk factors associated with thyroid nodules in patients with acromegaly. Sichuan Da Xue Xue Bao Yi Xue Ban 50: 433-437, 2019."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. D\u0105browska AM, Tarach JS, Kurowska M, Nowakowski A. Thyroid diseases in patients with acromegaly. Arch Med Sci 10: 837-845, 2014.","DOI":"10.5114\/aoms.2013.36924"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. W\u00fcster C, Steger G, Schmelzle A, Gottswinter J, Minne HW, Ziegler R. Increased incidence of euthyroid and hyperthyroid goiters independently of thyrotropin in patients with acromegaly. Horm Metab Res 23: 131-134, 1991.","DOI":"10.1055\/s-2007-1003632"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Sakane N, Yoshida T, Shimatsu A, Umekawa T, Kondo M. Octreotide and bromocriptine suppress thyroid hormone levels and thyroid nodule in an acromegalic patient with nontoxic autonomous goiter. Endocr J 44: 305-310, 1999.","DOI":"10.1507\/endocrj.44.305"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Di Cerbo A, Pezzuto F, Di Cerbo A. Growth hormone and insulin-like growth factor 1 affect the severity of Graves' disease. Endocrinol Diabetes Metab Case Rep 2017: 17-0061, 2017.","DOI":"10.1530\/EDM-17-0061"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Halloul I, Abdelkerim AB, Saad G, et al. Association of an empty sella and grave's disease in a patient with acromegaly: a case report. Pan Afr Med J 38: 394, 2021.","DOI":"10.11604\/pamj.2021.38.394.25034"},{"key":"7","unstructured":"7. Charkes ND. Graves' disease with functioning nodules (Marine-Lenhart syndrome). J Nucl Med 13: 885-892, 1972."},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Carnell NE, Valente WA. Thyroid nodules in Graves' disease: classification, characterization, and response to treatment. Thyroid 8: 647-652, 1998.","DOI":"10.1089\/thy.1998.8.647"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Plotuna I\u015e, Bala\u015f M, Golu I, et al. A rare form of hyperthyroidism leading to the diagnosis of acromegaly: a case report. Exp Ther Med 26: 477, 2023.","DOI":"10.3892\/etm.2023.12176"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Tseng FY, Chen YT, Chi YC, Chen PL, Yang WS. Serum levels of insulin-like growth factor 1 are negatively associated with log transformation of thyroid-stimulating hormone in Graves' disease patients with hyperthyroidism or subjects with euthyroidism: a prospective observational study. Medicine (Baltimore) 98: e14862, 2019.","DOI":"10.1097\/MD.0000000000014862"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Mo C, Zhong L. The effect of acromegaly on thyroid disease. Endocr J 70: 1051-1060, 2023.","DOI":"10.1507\/endocrj.EJ23-0356"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Geelhoed-Duijvestijn PH, Roelfsema F, Schr\u00f6der-van der Elst JP, van Doorn J, van der Heide D. Effect of administration of growth hormone on plasma and intracellular levels of thyroxine and tri-iodothyronine in thyroidectomized thyroxine-treated rats. J Endocrinol 133: 45-49, 1992.","DOI":"10.1677\/joe.0.1330045"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Lechan RM, Fekete C. The TRH neuron: a hypothalamic integrator of energy metabolism. Prog Brain Res 153: 209-235, 2006.","DOI":"10.1016\/S0079-6123(06)53012-2"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Clark R. The somatogenic hormones and insulin-like growth factor-1: stimulators of lymphopoiesis and immune function. Endocr Rev 18: 157-179, 1999.","DOI":"10.1210\/edrv.18.2.0296"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Yoshida A, Ishioka C, Kimata H, Mikawa H. Recombinant human growth hormone stimulates B cell immunoglobulin synthesis and proliferation in serum-free medium. Acta Endocrinol (Copenh) 126: 524-529, 1996.","DOI":"10.1530\/acta.0.1260524"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. De Gregorio G, Coppa A, Cosentino C, et al. The p85 regulatory subunit of PI3K mediates TSH-cAMP-PKA growth and survival signals. Oncogene 26: 2039-2047, 2007.","DOI":"10.1038\/sj.onc.1210011"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. De Bellis A, Bizzarro A, Pivonello R, Lombardi G, Bellastella A. Prolactin and autoimmunity. Pituitary 8: 25-30, 2005.","DOI":"10.1007\/s11102-005-5082-5"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Nomoto H, Kameda H, Nakamura A, et al. Breakdown of autonomously functioning thyroid nodule accompanied by acromegaly after octreotide treatment. Front Endocrinol (Lausanne) 10: 131, 2019.","DOI":"10.3389\/fendo.2019.00131"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Yoshinari M, Tokuyama T, Kuroda T, et al. Preserved thyroidal secretion of thyroxine in acromegalic patients with suppressed hypophyseal secretion of thyrotrophin. Clin Endocrinol (Oxf) 36: 355-360, 1992.","DOI":"10.1111\/j.1365-2265.1992.tb01460.x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/15\/65_5550-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T04:13:42Z","timestamp":1785557622000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/15\/65_5550-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":19,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5550-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,1]]},"article-number":"5550-25"}}